HMGB1 as a cytokine and therapeutic target

Journal of Endotoxin Research

Volumn 8, Issue 6, 2002, Pages 469-472

  Yang, Huan ^a   Wang, Haichao ^a   Czura, Christopher J ^a   Tracey, Kevin J ^a  

^a North Shore Long Island Jewish Research Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOPLASM PROTEIN; DNA BINDING PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN ANTIBODY; LIPOPOLYSACCHARIDE; NUCLEAR PROTEIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTOXEMIA; GENETIC TRANSCRIPTION; INFLAMMATION; LUNG INJURY; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOSOME; PASSIVE IMMUNIZATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SEPSIS; TRANSCRIPTION REGULATION;

ANTIBODIES; CYTOKINES; ENDOTOXEMIA; HMGB1 PROTEIN; HUMANS; IMMUNIZATION, PASSIVE; INFLAMMATION; MACROPHAGES;

ANIMALIA; MAMMALIA;

EID: 0036957367     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805102125001091     Document Type: Review

References (21)

1. Bustin M. Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci 2001; 26: 152-153
2. Goodwin GH, Sanders C, Johns EW. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem 1973; 38: 14-19
3. Bustin M, Lehn DA, Landsman D. Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta 1990; 1049: 231-243
4. Bustin M, Reeves R. High mobility group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 1996; 54: 35-100
5. Landsman D, Bustin M. A signature for the HMG-1 box DNA-binding proteins. Bioessays 1993; 15: 539-546
6. Degryse B, Bonaldi T, Scaffidi P et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 2001; 152: 1197-1206
7. Muller S, Scaffidi P, Degryse B et al. The double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J 2001; 16: 4337-4340
8. Yang H, Wang HC, Tracey KJ. HMG-1 re-discovered as a cytokine. Shock 2001; 15: 247-253
9. Wang H, Bloom O, Zhang M et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248-251
10. Wang H, Vishnubhakat JM, Bloom O et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999; 126: 389-392
11. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195
12. Gardella S, Andrei C, Ferrera D et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Reports 2002; 3: 995-1001
13. Andersson U, Wang H, Palmblad K et al. HMG-1 stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000; 192: 565-570
14. Agnello D, Wang H, Yang H, Tracey KJ, Ghezzi P. HMGB1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 2002; 18: 231-236
15. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as a mediator of acute lung injury. J Immunol 2000; 165: 2950-2954
16. Sappington PL, Yang R, Yang H, Tracey KJ, Delude RL, Fink MP. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers; and impairs intestinal barrier function in mice. J Gastroenterol 2002; 123: 790-802
17. Ombrellino M, Wang H, Ajemian MS et al. Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock. Lancet 2000; 354: 1446-1447
18. Kokkola R, Sundberg E, Ulfgren A-K et al. High mobility group box chromosomal protein 1 (HMGB1)-a novel proinflammatory mediator in synovitis. Arthritis Rheum 2002; 46: 2598-2603
19. Galanos C, Freudenberg MA, Reutter W. Galactosamine-induced sensitisation of the lethal effects of endotoxin. Proc Natl Acad Sci USA 1979; 76: 5939-5943
20. Lehmann V, Freudenberg MA, Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med 1987; 165: 657-663
21. Wichmann MW, Haisken JM, Ayala A, Chaudry IH. Melatonin administration following hemorrhagic shock decreases mortality from subsequent septic challenge. J Surg Res 1996; 65: 109-114